Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
about
The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysisOverexpression of squamous cell carcinoma antigen variants in hepatocellular carcinomaAssociation between hepatitis B virus and pancreatic cancerClinical Profiles of Chronic Hepatitis C in a Major County Medical Center Outpatient Setting in United States.Natural history and treatment of hepatitis B virus and hepatitis C virus coinfectionGenetic variation of occult hepatitis B virus infectionHepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendationsRole of occult hepatitis B virus infection in chronic hepatitis CThyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspectiveOccult hepatitis B virus infectionClinical impact of occult hepatitis B virus infection in immunosuppressed patientsMiR-122 in hepatitis B virus and hepatitis C virus dual infectionHepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection.The science, economics, and effectiveness of combination therapy for hepatitis CPathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiologyHepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patientsDefective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis CHBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markersRegulation of Hepatitis B Virus Replication by the Phosphatidylinositol 3-Kinase-Akt Signal Transduction PathwayMolecular mechanisms underlying occult hepatitis B virus infection.Current hepatitis B virus infection situation in Indonesia and its genetic diversityThe epidemiology of hepatitis C in a UK health regional population of 5.12 millionHuman immunodeficiency and hepatitis virus infections and their associated conditions and treatments among people with haemophilia.Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C.Occult HBV infection: a faceless enemy in liver cancer development.Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece.Occult hepatitis B virus and hepatocellular carcinomaImmunogenicity of recombinant hepatitis B virus vaccine in patients with and without chronic hepatitis C virus infection: a case-control study.Isolated antibody to hepatitis B core antigen in patients with chronic hepatitis C virus infection.Immunogenicity of recombinant hepatitis B vaccine in treatment-naive and treatment-experienced chronic hepatitis C patients: the effect of pegylated interferon plus ribavirin treatmentPrevalence of occult HBV infection in haemodialysis patients with chronic HCV.Molecular characterization of occult hepatitis B virus infection in patients with end-stage liver disease in Colombia.Hepatitis C virus/human immunodeficiency virus coinfection: clinical management issues.Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.Treatment of chronic hepatitis C virus infection in patients with cirrhosis.Hepatocellular carcinoma in patients with chronic hepatitis C virus infection without cirrhosis.Serological and molecular expression of Hepatitis B infection in patients with chronic Hepatitis C from Tunisia, North Africa.Spontaneous HBsAg loss in Korean patients: relevance of viral genotypes, S gene mutations, and covalently closed circular DNA copy numbers.Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapyRecent insights on risk factors of hepatocellular carcinoma
P2860
Q21245094-31A1D7C2-1976-4169-BC81-9062A61FCB75Q24645168-05694423-234D-4DD0-83DD-462040453A98Q24656650-A6CA469E-7A28-47A0-9F5E-5534541A21E1Q24791398-2ECDD61E-4DBB-452B-AE83-FCA99B06B767Q24815355-B48DE5B0-5769-42DA-BFE6-5CCAA6E6E77DQ26751031-7A131647-0198-4049-8F54-6F3F5BC2913BQ26784247-D38CAE25-227B-4D37-B247-DA2D3272474DQ26823538-577CF063-D643-49A8-96F1-415D6384A7EDQ26827517-EA5EC50D-DBA9-4469-8F2B-7E4198DD5AB2Q27004224-473F4459-3FD3-4D10-BC14-2D6D5D315A70Q27006996-C3C8A3AD-4CB5-47EE-85F5-E2C5BA93F7C9Q27008894-E0D65DDA-340D-4DD3-BC53-A7D1F1D8E919Q27472769-16DBD335-6195-4EBB-8843-3D84B3733D87Q27477845-FC38D3DC-2A0E-4104-9D3D-055414C599EEQ27477846-A2912566-1A47-41DA-8E1F-5AB149B085C0Q27477975-92F2EA85-506E-4561-A53A-39B4497FC899Q27478298-E4597935-350D-4341-966A-738D4DD77E3AQ27478342-4FB046E2-4D25-41CE-B2CE-A0E61B7E6845Q27481454-9140DDAC-CEB0-432E-A245-EE7C21201C34Q27686923-3298099D-6AD7-46EB-A155-9D56FC3E6603Q28074068-B9B418E8-741A-44A3-BCD9-14A474ADD736Q28362636-FB974B3F-138E-4E9E-8D20-6831739FB2E0Q33363196-CB493A7F-2805-457D-A2A0-B2E75A2AC540Q33373813-EAF73C1A-7C91-4884-8F31-B5F22EC48D36Q33584773-E476044A-F450-4170-BF4C-1323BCB4C0A1Q33590821-B70323A9-3C2F-46DA-9909-1EE168DE97EBQ33661018-6303D7D4-54EC-4F6C-BE6E-0EA60BC85500Q33787868-E02C2B62-DD6D-4A0F-A4B3-3D2ED6EE225AQ33867583-C1AA1F98-1A6C-4B9E-B526-ADD7FC0087C7Q33867600-96371CC6-5D3F-4343-82FA-7561F01B3D1EQ33867994-77E6D3B0-6395-41F7-B785-BD2F72B8D151Q33883921-11DB7C3F-01DD-4F30-8FDD-2D7CD28735EDQ33982898-29EB0F77-EAD2-43B8-963E-A39B63FCB28CQ33984190-799374B4-A84A-48E7-B341-7C009CDE46CBQ34022678-70919B88-90FD-4CE8-AA03-AFFBDC3AC282Q34084962-3741D57C-C59C-4BF2-9546-40E88D167BCCQ34174479-1F54172E-0D5A-4970-80FB-9E71555B7611Q34339599-53C9351C-4B21-489D-B86C-5B6FC2F66C8BQ34387913-7703DD06-52F4-4109-83BE-60CA93F1F0FDQ34391482-37068664-C56D-4FF0-80ED-774311C2CF89
P2860
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
@en
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
@nl
type
label
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
@en
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
@nl
prefLabel
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
@en
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
@nl
P2093
P1476
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
@en
P2093
Cacciola I
Cerenzia G
Orlando ME
Raimondo G
Squadrito G
P356
10.1056/NEJM199907013410104
P407
P577
1999-07-01T00:00:00Z